An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)

Clinical trial NCT02279095 · COMPLETED

Trial details

NCT number: NCT02279095
Sponsor: Clementia Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fibrodysplasia Ossificans Progressiva

Start date: 2014-10-09
Primary completion: 2022-09-20
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.